questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins antiviraux
Vaccins antiviraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Hepatitis B Surface Antigens
Diagnostic
5
Infections virales
Tests diagnostiques
Vaccins antiviraux
Tests sérologiques
Symptômes
Vaccins antiviraux
Efficacité des vaccins
Études cliniques
Symptômes
5
Symptômes
Vaccins antiviraux
Effets secondaires
Vaccins antiviraux
Infections virales
Effets secondaires
Types de vaccins
Réponse immunitaire
Infections virales
Symptômes
Prévention
5
Prévention
Vaccins antiviraux
Vaccins antiviraux
Grossesse
Souches virales
Vaccins antiviraux
Vaccination de masse
Immunité collective
Traitements
5
Vaccins antiviraux
Traitements antiviraux
Antiviraux
Infections virales
Vaccins antiviraux
Symptômes
Vaccination
Traitements antiviraux
Vaccins antiviraux
Prévention
Complications
5
Complications
Réactions allergiques
Complications
Vaccins antiviraux
Gestion des complications
Vaccins antiviraux
Profils de complications
Vaccins antiviraux
Facteurs de risque
5
Facteurs de risque
Infections virales
Antécédents médicaux
Vaccination
Voyages
Infections virales
Personnes âgées
Complications
Mode de vie
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins antiviraux : Questions médicales les plus fréquentes",
"headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-adénovirus",
"alternateName": "Adenovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D062705",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-adénovirus",
"code": {
"@type": "MedicalCode",
"code": "D062705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA",
"alternateName": "AIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D016915",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA",
"code": {
"@type": "MedicalCode",
"code": "D016915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la COVID-19",
"alternateName": "COVID-19 Vaccines",
"url": "https://questionsmedicales.fr/mesh/D000086663",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la COVID-19",
"code": {
"@type": "MedicalCode",
"code": "D000086663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin ChAdOx1 nCoV-19",
"alternateName": "ChAdOx1 nCoV-19",
"url": "https://questionsmedicales.fr/mesh/D000090985",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin ChAdOx1 nCoV-19",
"code": {
"@type": "MedicalCode",
"code": "D000090985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.063"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ad26COVS1",
"alternateName": "Ad26COVS1",
"url": "https://questionsmedicales.fr/mesh/D000090984",
"about": {
"@type": "MedicalCondition",
"name": "Ad26COVS1",
"code": {
"@type": "MedicalCode",
"code": "D000090984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.125"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le cytomégalovirus",
"alternateName": "Cytomegalovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022482",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le cytomégalovirus",
"code": {
"@type": "MedicalCode",
"code": "D022482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la dengue",
"alternateName": "Dengue Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053059",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la dengue",
"code": {
"@type": "MedicalCode",
"code": "D053059",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie à virus Ebola",
"alternateName": "Ebola Vaccines",
"url": "https://questionsmedicales.fr/mesh/D046129",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie à virus Ebola",
"code": {
"@type": "MedicalCode",
"code": "D046129",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.205"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les herpèsvirus",
"alternateName": "Herpesvirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022283",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les herpèsvirus",
"code": {
"@type": "MedicalCode",
"code": "D022283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la varicelle",
"alternateName": "Chickenpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D019433",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la varicelle",
"code": {
"@type": "MedicalCode",
"code": "D019433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus herpès simplex",
"alternateName": "Herpes Simplex Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022301",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus herpès simplex",
"code": {
"@type": "MedicalCode",
"code": "D022301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie de Marek",
"alternateName": "Marek Disease Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022501",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie de Marek",
"code": {
"@type": "MedicalCode",
"code": "D022501",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antigrippaux",
"alternateName": "Influenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D007252",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antigrippaux",
"code": {
"@type": "MedicalCode",
"code": "D007252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.302"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre l'encéphalite japonaise",
"alternateName": "Japanese Encephalitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre l'encéphalite japonaise",
"code": {
"@type": "MedicalCode",
"code": "D022321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole",
"alternateName": "Measles Vaccine",
"url": "https://questionsmedicales.fr/mesh/D008458",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole",
"code": {
"@type": "MedicalCode",
"code": "D008458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.404"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiourlien",
"alternateName": "Mumps Vaccine",
"url": "https://questionsmedicales.fr/mesh/D009108",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiourlien",
"code": {
"@type": "MedicalCode",
"code": "D009108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les papillomavirus",
"alternateName": "Papillomavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053918",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D053918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",
"url": "https://questionsmedicales.fr/mesh/D000068857",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"code": {
"@type": "MedicalCode",
"code": "D000068857",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus para-influenza",
"alternateName": "Parainfluenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022241",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus para-influenza",
"code": {
"@type": "MedicalCode",
"code": "D022241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antipoliomyélitiques",
"alternateName": "Poliovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D023321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antipoliomyélitiques",
"code": {
"@type": "MedicalCode",
"code": "D023321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique inactivé",
"alternateName": "Poliovirus Vaccine, Inactivated",
"url": "https://questionsmedicales.fr/mesh/D011054",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique inactivé",
"code": {
"@type": "MedicalCode",
"code": "D011054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique oral",
"alternateName": "Poliovirus Vaccine, Oral",
"url": "https://questionsmedicales.fr/mesh/D011055",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique oral",
"code": {
"@type": "MedicalCode",
"code": "D011055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie d'Aujeszky",
"alternateName": "Pseudorabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022421",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie d'Aujeszky",
"code": {
"@type": "MedicalCode",
"code": "D022421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.632"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antirabiques",
"alternateName": "Rabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D011819",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antirabiques",
"code": {
"@type": "MedicalCode",
"code": "D011819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"alternateName": "Respiratory Syncytial Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022261",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"code": {
"@type": "MedicalCode",
"code": "D022261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-rotavirus",
"alternateName": "Rotavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022243",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-rotavirus",
"code": {
"@type": "MedicalCode",
"code": "D022243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antirubéoleux",
"alternateName": "Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012411",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antirubéoleux",
"code": {
"@type": "MedicalCode",
"code": "D012411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"alternateName": "Measles-Mumps-Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022542",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"code": {
"@type": "MedicalCode",
"code": "D022542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA simien",
"alternateName": "SAIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D018449",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA simien",
"code": {
"@type": "MedicalCode",
"code": "D018449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antivariolique",
"alternateName": "Smallpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012900",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antivariolique",
"code": {
"@type": "MedicalCode",
"code": "D012900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.859"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les hépatites virales",
"alternateName": "Viral Hepatitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D014761",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales",
"code": {
"@type": "MedicalCode",
"code": "D014761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite A",
"alternateName": "Hepatitis A Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022362",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D022362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.395"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite B",
"alternateName": "Hepatitis B Vaccines",
"url": "https://questionsmedicales.fr/mesh/D017325",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D017325",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le virus du Nil occidental",
"alternateName": "West Nile Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053060",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le virus du Nil occidental",
"code": {
"@type": "MedicalCode",
"code": "D053060",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.962"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiamaril",
"alternateName": "Yellow Fever Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022341",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiamaril",
"code": {
"@type": "MedicalCode",
"code": "D022341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.970"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux",
"alternateName": "Viral Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D014765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yukai Huang",
"url": "https://questionsmedicales.fr/author/Yukai%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Xiao Guo",
"url": "https://questionsmedicales.fr/author/Xiao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuancheng Zhou",
"url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Dongying Liu",
"url": "https://questionsmedicales.fr/author/Dongying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jingrui Mao",
"url": "https://questionsmedicales.fr/author/Jingrui%20Mao",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36642151",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.01.005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon-based therapy.",
"datePublished": "2022-08-13",
"url": "https://questionsmedicales.fr/article/35871534",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jvh.13734"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8",
"datePublished": "2023-10-18",
"url": "https://questionsmedicales.fr/article/37920475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1257113"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36411952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/apt.17306"
}
},
{
"@type": "ScholarlyArticle",
"name": "A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays.",
"datePublished": "2022-12-23",
"url": "https://questionsmedicales.fr/article/36623378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcv.2022.105375"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins antiviraux",
"item": "https://questionsmedicales.fr/mesh/D014765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins antiviraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins antiviraux",
"description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Hepatitis+B+Surface+Antigens#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins antiviraux",
"description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Hepatitis+B+Surface+Antigens#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins antiviraux",
"description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Hepatitis+B+Surface+Antigens#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins antiviraux",
"description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Hepatitis+B+Surface+Antigens#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins antiviraux",
"description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Hepatitis+B+Surface+Antigens#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins antiviraux",
"description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Hepatitis+B+Surface+Antigens#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les vaccins antiviraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité."
}
},
{
"@type": "Question",
"name": "Les symptômes indiquent-ils un besoin de vaccin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un vaccin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un vaccin antiviral ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des vaccins sont-ils fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers."
}
},
{
"@type": "Question",
"name": "Comment distinguer une infection d'un effet secondaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de vaccin ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils similaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue."
}
},
{
"@type": "Question",
"name": "Comment les vaccins antiviraux préviennent-ils les infections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques."
}
},
{
"@type": "Question",
"name": "À quel âge doit-on commencer la vaccination antivirale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre toutes les souches virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la vaccination de masse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles après infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils nécessaires après vaccination ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après vaccination ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-vaccinales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le vaccin ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter l'immunité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections virales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la vaccination ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les personnes âgées ont-elles plus de risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
, Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Publications dans "Vaccins antiviraux" :
Seroclearance of hepatitis B surface antigen (HBsAg) indicates functional cure for hepatitis B virus (HBV) infection. Low HBsAg levels can predict HBsAg seroclearance over time. However, little is kno...
We conducted a retrospective cohort study including 2614 treatment-naïve patients with chronic HBV infection who received long-term follow-up at the National Taiwan University Hospital. The primary en...
There were 465 patients who cleared HBsAg with 32,414.72 person-years of follow-up, with a mean clearance rate of 1.43% per year. We found that lower HBcrAg levels at baseline were associated with an ...
Lower serum HBcrAg levels were associated with increased probability of HBsAg seroclearance over time. In patients with HBsAg levels >1000 IU/mL, clearing HBcrAg may serve as an early biomarker for HB...
It is unclear whether hepatitis B surface antibody (HBsAb) confers clinical benefits after HBsAg seroclearance, especially in hepatitis B surface antigen (HBsAg) seroreversion and maintenance of HBsAb...
Despite treatment, hepatitis B surface antigen (HBsAg) persists in patients with chronic hepatitis B (CHB), suggesting the likely presence of the virus in the body. CD8...
Hepatitis B surface antigen (HBsAg) seroconversion is sometimes observed in hepatitis B reactivation (rHBV), probably due to immune resetting and differentiation....
To investigate sequential immune differentiation and abrogation of tolerance in patients with rHBV who achieved HBsAg seroconversion....
We included 19 patients with chronic hepatitis B (CHBV; HBV DNA log10...
At 24 weeks, 81% rHBV (n = 67) lost HBV DNA and HBeAg (41%), and 12 (19%) lost HBsAg and made anti-HBs titers >10 IU/ml. rHBV patients had higher Th1/17, T...
Non-seroconverters have increased inhibitory markers on CD4/CD8 T cells. There is a critical play of CD8, Tfh and B cells and subsets in seroclearance, along with checkpoint molecules as a potential t...
This study aimed to evaluate the usefulness of two novel assays, namely the iTACT-hepatitis B surface antigen (iTACT-HBsAg) and iTACT-hepatitis B core-related antigen (iTACT-HBcrAg) assays, in chronic...
HBsAg and HBcrAg were measured by the two iTACT-assays in 556 serial sera collected from 96 CHB patients at 7 different time points spanning from 5 years before to 10 years after SC and 120 HBsAg-nega...
Using the iTACT-assays, HBsAg was detectable in 154/418 (36.8%) samples collected after SC. HBcrAg was detectable in 78.3% and 65.9% of samples collected before and after SC, respectively. The detecta...
The iTACT assays detected a low level of HBsAg and/or HBcrAg in >70% of patients even at 10 years after SC, suggesting that CHB patients with SC still harbour a low level of HBV protein expression. Th...
Hepatitis B surface antigen (HBsAg) seroclearance is an optimal therapeutic endpoint, as it reflects the amount of covalently closed circular DNA. The exact mechanisms that contribute to HBsAg reducti...
Predicting hepatitis B surface antigen (HBsAg) clearance is important for chronic hepatitis B (CHB) patients receiving pegylated interferon-alfa (Peg-IFN) therapy. We aimed to determine the predictive...
The interaction of multiple viruses in one host is thought to enhance the development of mutations. However, the impact of hepatitis D virus (HDV) positivity on the development of unique hepatitis B v...
To prevent misreporting of false positives in the hepatitis B surface antigen (HBsAg) assay, it is recommended to confirm the low-positive cases with neutralization tests. However, currently not many ...
In this retrospective cohort study, we analyzed 47,305 patients who had their HBsAg value measured at Sapporo Medical University Hospital between November 2016 and March 2022. The patients eligible fo...
HBsAg quantitative tests were performed in 71,475 tests. Of these, 817 tests and 376 patients were subjected to neutralization tests. Of the patients who met the criteria, 329 were included in this st...
Confirmatory neutralization tests should be performed at least in the range of 0.005-0.049 IU/mL where quantification is possible with a higher-sensitivity assay....
Hepatitis B surface antigen (HBsAg) seroclearance remains uncommon in chronic hepatitis B (CHB) infection. During acute flares of CHB (AFOCHB), alanine aminotransferase elevation reflects a mounting i...
A total of 75 patients with severe AFOCHB with alanine aminotransferase 10× the upper limit of normal were matched to a control group by age and sex in a 1:2 ratio. qHBsAg levels were measured at the ...
The median follow-up times for patients with severe AFOCHB and controls were 8.8 and 10.5 years, respectively. The cumulative rate of HBsAg seroclearance was higher in the severe AFOCHB group than in ...
Severe AFOCHB was associated with a greater incidence of HBsAg seroclearance and qHBsAg decline. However, it was associated with a higher incidence of hepatocellular carcinoma....